Nephros Inc. (NEPH) is a publicly traded Healthcare sector company. As of July 6, 2026, NEPH trades at $3.53 with a market cap of $36.91M and a P/E ratio of 56.67. NEPH moved +0.00% today. Year to date, NEPH is -27.97%; over the trailing twelve months it is -14.57%. Its 52-week range spans $1.39 to $6.42. Analyst consensus is buy with an average price target of $8.00. Rallies surfaces NEPH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for NEPH combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $3.53 |
| Market Cap | $36.91M |
| P/E Ratio | 56.67 |
| EPS | $0.06 |
| Dividend Yield | 0.00% |
| 52-Week High | $6.42 |
| 52-Week Low | $1.39 |
| Volume | 2.19K |
| Avg Volume | 0 |
| Revenue (TTM) | $19.12M |
| Net Income | $776.00K |
| Gross Margin | 59.95% |
1 analysts cover NEPH: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $8.00.